Abstract

Aurora B, together with IN-box, the C-terminal part of INCENP, forms an enzymatic complex that ensures faithful cell division. The [Aurora B/IN-box] complex is activated by autophosphorylation in the Aurora B activation loop and in IN-box, but it is not clear how these phosphorylations activate the enzyme. We used a combination of experimental and computational studies to investigate the effects of phosphorylation on the molecular dynamics and structure of [Aurora B/IN-box]. In addition, we generated partially phosphorylated intermediates to analyze the contribution of each phosphorylation independently. We found that the dynamics of Aurora and IN-box are interconnected, and IN-box plays both positive and negative regulatory roles depending on the phosphorylation status of the enzyme complex. Phosphorylation in the activation loop of Aurora B occurs intramolecularly and prepares the enzyme complex for activation, but two phosphorylated sites are synergistically responsible for full enzyme activity.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. The mass spectrometry proteomics data are available through the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD038935.

The following data sets were generated

Article and author information

Author details

  1. Dario Segura-Peña

    Centre for Molecular Medicine Norway, University of Oslo, Oslo, Norway
    For correspondence
    dario.segura-pena@ncmm.uio.no
    Competing interests
    The authors declare that no competing interests exist.
  2. Oda Hovet

    Centre for Molecular Medicine Norway, University of Oslo, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  3. Hemanga Gogoi

    Centre for Molecular Medicine Norway, University of Oslo, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  4. Jennine Dawicki-McKenna

    Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Stine Malene Hansen Wøien

    Centre for Molecular Medicine Norway, University of Oslo, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  6. Manuel Carrer

    Department of Chemistry, University of Oslo, Oslo, Norway
    Competing interests
    The authors declare that no competing interests exist.
  7. Ben E Black

    Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Michele Cascella

    Department of Chemistry, University of Oslo, Oslo, Norway
    For correspondence
    michele.cascella@kjemi.uio.no
    Competing interests
    The authors declare that no competing interests exist.
  9. Nikolina Sekulic

    Centre for Molecular Medicine Norway, University of Oslo, Oslo, Norway
    For correspondence
    nikolina.sekulic@ncmm.uio.no
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8027-9114

Funding

Norges Forskningsråd (187615)

  • Dario Segura-Peña
  • Oda Hovet
  • Hemanga Gogoi
  • Stine Malene Hansen Wøien
  • Nikolina Sekulic

Norges Forskningsråd (262695)

  • Oda Hovet
  • Manuel Carrer
  • Michele Cascella

Norwegian Supercomputing Program (NN4654K)

  • Oda Hovet
  • Manuel Carrer
  • Michele Cascella

Norges Forskningsråd (325528)

  • Nikolina Sekulic

National Institute of General Medical Sciences (R35-GM130302)

  • Jennine Dawicki-McKenna
  • Ben E Black

National Institute of General Medical Sciences (GM108360)

  • Jennine Dawicki-McKenna

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Sierra Cullati, Vanderbilt University, United States

Version history

  1. Preprint posted: November 24, 2022 (view preprint)
  2. Received: December 2, 2022
  3. Accepted: May 20, 2023
  4. Accepted Manuscript published: May 25, 2023 (version 1)
  5. Version of Record published: June 7, 2023 (version 2)

Copyright

© 2023, Segura-Peña et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,797
    views
  • 283
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Dario Segura-Peña
  2. Oda Hovet
  3. Hemanga Gogoi
  4. Jennine Dawicki-McKenna
  5. Stine Malene Hansen Wøien
  6. Manuel Carrer
  7. Ben E Black
  8. Michele Cascella
  9. Nikolina Sekulic
(2023)
The structural basis of the multi-step allosteric activation of Aurora B kinase
eLife 12:e85328.
https://doi.org/10.7554/eLife.85328

Share this article

https://doi.org/10.7554/eLife.85328

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Natalia Dolgova, Eva-Maria E Uhlemann ... Oleg Y Dmitriev
    Research Article

    Mediator of ERBB2-driven Cell Motility 1 (MEMO1) is an evolutionary conserved protein implicated in many biological processes; however, its primary molecular function remains unknown. Importantly, MEMO1 is overexpressed in many types of cancer and was shown to modulate breast cancer metastasis through altered cell motility. To better understand the function of MEMO1 in cancer cells, we analyzed genetic interactions of MEMO1 using gene essentiality data from 1028 cancer cell lines and found multiple iron-related genes exhibiting genetic relationships with MEMO1. We experimentally confirmed several interactions between MEMO1 and iron-related proteins in living cells, most notably, transferrin receptor 2 (TFR2), mitoferrin-2 (SLC25A28), and the global iron response regulator IRP1 (ACO1). These interactions indicate that cells with high MEMO1 expression levels are hypersensitive to the disruptions in iron distribution. Our data also indicate that MEMO1 is involved in ferroptosis and is linked to iron supply to mitochondria. We have found that purified MEMO1 binds iron with high affinity under redox conditions mimicking intracellular environment and solved MEMO1 structures in complex with iron and copper. Our work reveals that the iron coordination mode in MEMO1 is very similar to that of iron-containing extradiol dioxygenases, which also display a similar structural fold. We conclude that MEMO1 is an iron-binding protein that modulates iron homeostasis in cancer cells.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Isabelle Petit-Hartlein, Annelise Vermot ... Franck Fieschi
    Research Article

    NADPH oxidases (NOX) are transmembrane proteins, widely spread in eukaryotes and prokaryotes, that produce reactive oxygen species (ROS). Eukaryotes use the ROS products for innate immune defense and signaling in critical (patho)physiological processes. Despite the recent structures of human NOX isoforms, the activation of electron transfer remains incompletely understood. SpNOX, a homolog from Streptococcus pneumoniae, can serves as a robust model for exploring electron transfers in the NOX family thanks to its constitutive activity. Crystal structures of SpNOX full-length and dehydrogenase (DH) domain constructs are revealed here. The isolated DH domain acts as a flavin reductase, and both constructs use either NADPH or NADH as substrate. Our findings suggest that hydride transfer from NAD(P)H to FAD is the rate-limiting step in electron transfer. We identify significance of F397 in nicotinamide access to flavin isoalloxazine and confirm flavin binding contributions from both DH and Transmembrane (TM) domains. Comparison with related enzymes suggests that distal access to heme may influence the final electron acceptor, while the relative position of DH and TM does not necessarily correlate with activity, contrary to previous suggestions. It rather suggests requirement of an internal rearrangement, within the DH domain, to switch from a resting to an active state. Thus, SpNOX appears to be a good model of active NOX2, which allows us to propose an explanation for NOX2’s requirement for activation.